×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Skip to main content
Tags: monoclonal antibodies | shipments resume | omicron

Biden Admin Sends States Monoclonal Antibodies That Might Be Ineffective Against Omicron

Biden Admin Sends States Monoclonal Antibodies That Might Be Ineffective Against Omicron

Prep to administer the monocional antibody. Gov. Ron DeSantis held a news conference today, to speak about a new monoclonal antibody treatment center in Pembroke Pines, Florida. (Sipa via AP)

By    |   Monday, 10 January 2022 12:09 PM EST

The federal government has resumed sending states all three monoclonal antibody treatments authorized for early-stage coronavirus, even though evidence suggests two might be ineffective against omicron, The Washington Post reported on Monday.

Experts are split over the decision, with some worried that many of the costly treatments will be useless and cause confusion among patients. They are also concerned that treatment decisions will be difficult, because it can be hard for physicians to determine if patients are infected with the omicron or delta variant.

But other doctors are eager to receive treatments, even if they are less effective, because of a severe shortage of sotrovimab, the monoclonal antibody therapy that apparently works best against omicron. These experts say they would rather have some monoclonal antibodies than none, especially since some of their patients may be infected by the delta variant, which is still prevalent is some areas of the country.

David Kessler, the chief scientific officer for the Biden administration’s COVID-19 response, said the government has made clear that the two that don’t work against omicron should be used "only if the delta variant represents a significant proportion of infections in the region, and then only with the explicit understanding that these treatments would be ineffective if the patients are infected with the omicron variant,” according to The Washington Post.

Florida Gov. Ron DeSantis, one of the most vocal proponents of monoclonal antibody treatments who complained that the Biden administration late last month halted shipments of the two other such treatments shown to be less effective against omicron, made by Regeneron Pharmaceuticals and Eli Lilly, took credit in a press release for forcing the administration to resume shipments.

DeSantis and some physicians have said the Regeneron treatments could help in areas where the delta variant is still infecting people, with the governor adding that he is not convinced that these treatments were ineffective against omicron.

The Regeneron and Lilly medications, which are given to outpatients by infusion or injection, are free and have caused few side effects.

But experts are concerned that in the vast majority of cases, physicians making treatment decisions do not know whether their patient is infected by omicron or delta, because little genomic sequencing is being done, with most hospitals not having the capability to do real-time sequencing to determine how to treat individual patients, The Washington Post reported.

Even when tests are sequenced, the results are usually too late for a decision on treatment.

© 2022 Newsmax. All rights reserved.


Newsfront
The federal government has resumed sending states all three monoclonal antibody treatments authorized for early-stage coronavirus, even though evidence suggests two might be ineffective against omicron.
monoclonal antibodies, shipments resume, omicron
409
2022-09-10
Monday, 10 January 2022 12:09 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved
Download the NewsmaxTV App
NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved